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accine. Information in thispaperwasusedbyanti-vaccineactivists
o argue against the use of MMR and led to decreased coverage and
esultant measles outbreaks.
A policy change in 1999 recommended by the American
cademy of Pediatrics and the US Centers for Disease Control to
emove thimerosal from vaccines fueled the rumor that thimerosal
aused autism. This rumor resulted in thousands of claims of vac-
ine injury and a decrease in the rate of neonatal hepatitis B
mmunization.
In 2003 religious and political leaders in Nigeria encouraged
oycotts of oral polio vaccine, claiming that it was contaminated
ith HIV and could cause sterilization in vaccinees. This politi-
ally motivated assertion resulted in a polio outbreak in Nigeria
nd subsequent polio outbreaks in 15 other countries.
A 1994 report on a birth control vaccine using tetanus toxoid as
carrier sparked a rumor that tetanus toxoid could cause sterility.
his misinformation, spread by Catholic organizations through 60
ountries in South and Central America, resulted in a 45% drop in
accination coverage.
The intuitive approach to combating vaccinemyths is to provide
actual information to refute the myth. The method by which the
actual information is presented is important. Research onmemory
erformance demonstrated that repetition of a myth in order to
efute it frequently led to the false information being remembered
s true.
To effectively face anti-vaccine movements the full range of
olitical, cultural, and psychological factors affecting individual
ecision making must be considered and used in building public
rust. In view of the way human memory works, presentation and
epetition of facts should replace reiteration of the false myths.
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The science of transplantation has advanced tremendously
ince the discovery of immunosuppressive agents. With the potent
mmunosuppressive agents but less adverse effects, patient can live
onger and has better quality of life. In order to achieve this goal,
re-transplant evaluation is crucial in decreasing and eliminating
nfectious complications after immunosuppression.
The objectives of pre-transplant evaluation are to identify and
reat active infection, deﬁne the risk of infection and implement
he strategies to prevent infection post-transplant period.
Detail history taking is the key to successfully managing and
reventing infectious complication pre- and post-transplantation.
erological and immunological tests for infections, such as her-
es virus, syphilis, HIV and Mycobacterium tuberculosis, identify
atients with latent infections which lead to pre-transplant vac-
ination, treatment and appropriate post-transplant antimicrobial
rophylaxis. Patient with active infection should be treated in
imely fashion prior to intense immunosuppression to avoid exac-
rbation of the disease. History of travel, occupation and daily
ctivity suggests speciﬁc tests of infections in each geographicalnfectious Diseases 16S (2012) e2–e157
area. Life-style modiﬁcation is recommended in order to decrease
exposure to infection pre- and post-transplantation.
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Donor derived infections
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Infections are a signiﬁcant complication of solid organ trans-
plantations (SOT). Although many of these infections are due to
surgical complications and pre- and posttransplant exposure of
immunocompromised individuals to pathogens in the hospital
and in their daily activities at home, another potential source of
infection in these individuals derives from their donors. Usually
cadaveric donors are not known and family members giving con-
sent may not know all of their history. In such cases the life saving
organs can potentially pose a threat to the lives of the recipients
they were meant to save.
Several methods can decrease risk of this occurring: screen-
ing of donor medical, social, and travel history, and screening of
donor blood for not only common infectious contraindications,
such as HIV and viral hepatitis, but also infections endemic to
their travel history. Additionally, having tightly regulated policies,
autopsy conﬁrmation of cause of death and comorbidities of donor,
and ease of communication between transplant centers can con-
tribute to decreasing morbidity and mortality from donor derived
infections.
Having a framework in place to address the risk of donor derived
infections at numerous levels is key to decreasing the likelihood
of this potentially catastrophic event, which can affect numerous
recipients’ lives.
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State of the art: Transplantation in HIV infected individuals
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The introduction of Highly Active Antiretroviral Therapy in the
mid-1990’s has had a signiﬁcant impact in the morbidity and
mortality of patients infected with the Human Immunodeﬁciency
Virus (HIV). Diseases previously deemed untreatable in this patient
population are now the focus of intense research. Cirrhosis and
decompensated liver disease, secondary to a more rapid progres-
sion of Hepatitis C virus infection, and end-stage renal disease,
cause signiﬁcant morbidity in otherwise healthy and virologically
